P&K Skin Research Center Co., Ltd. (347740.KQ) Financial Forecast
South Korea · Health Care · KRW (Millions) · Annual
Key financials
KRW|Millions
ROE
5.95%
2025 (actual)
ROA
5.56%
2025 (actual)
Gross Margin
47.02%
2025 (actual)
Net Margin
20.56%
2025 (actual)
Total Assets
₩86,524.35M
2025 (actual)
Net Income
₩4,685.34M
2025 (actual)
Valuation
₩73,937.38M
2026 (forecast)
Stock Price
₩2,560
Historical & projected performance
KRW|Millions
Reported figures and Equlion model projections for the next 5 years.
ROE
-6.4 pt
Company
ROA
-5.9 pt
Company
Gross Margin
-14.2 pt
Company
Sector average
Net Margin
-21.6 pt
Company
Total Assets
+64.7%
Company
Sector average (own scale)
Net Income
-109.5%
Company
Valuation
-66.2%
Company
Sector average (own scale)
Stock Price
-66.2%
Company
Sector average (own scale)
Amounts in KRW (millions); stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Stock price and valuation carry no data date: they are the Equlion model's estimate for 2026. Projections are model estimates, not investment advice.
Want the full financial forecast report for P&K Skin Research Center Co., Ltd.? It covers the balance sheet, income statement, cash flow and Equlion model projections.